Oxford Cannabinoid Technologies Investor Relations Material
Latest events
H2 2024
24 Nov, 2024
H1 2023
29 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oxford Cannabinoid Technologies Holdings PLC
Access all reports
Oxford Cannabinoid Technologies Holdings PLC is a UK-based pharmaceutical company focused on developing prescription cannabinoid-based therapies. The company targets conditions including chronic pain and neurological disorders, advancing its drug candidates through preclinical and clinical development phases. It operates within a regulated scientific framework and collaborates with academic partners. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
OCTH
Country
🇬🇧 United Kingdom